L.S. Boers

968 total citations
8 papers, 83 citations indexed

About

L.S. Boers is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, L.S. Boers has authored 8 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in L.S. Boers's work include COVID-19 Clinical Research Studies (4 papers), Respiratory Support and Mechanisms (4 papers) and Intensive Care Unit Cognitive Disorders (2 papers). L.S. Boers is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Respiratory Support and Mechanisms (4 papers) and Intensive Care Unit Cognitive Disorders (2 papers). L.S. Boers collaborates with scholars based in Netherlands, United Kingdom and Australia. L.S. Boers's co-authors include Lieuwe D. J. Bos, Alexander P. J. Vlaar, Esther J. Nossent, Tom van der Poll, JanWillem Duitman, Leo Heunks, Robert F. J. Kullberg, Justin de Brabander, Peter I. Bonta and Marcus J. Schultz and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Thorax and American Journal of Physiology-Lung Cellular and Molecular Physiology.

In The Last Decade

L.S. Boers

6 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L.S. Boers Netherlands	5	41	30	22	21	19	8	83
Haopu Yang China	5	39 1.0×	15 0.5×	23 1.0×	28 1.3×	33 1.7×	8	87
Björn P. Persson Sweden	5	27 0.7×	33 1.1×	27 1.2×	12 0.6×	2 0.1×	5	82
Maíra Nilson Benatti Brazil	3	16 0.4×	29 1.0×	28 1.3×	28 1.3×	9 0.5×	6	81
Jos A. H. van Oers Netherlands	6	11 0.3×	32 1.1×	34 1.5×	11 0.5×	6 0.3×	12	77
Emőke Almásy Romania	6	12 0.3×	13 0.4×	31 1.4×	9 0.4×	11 0.6×	10	70
Maximilian Münchhoff Germany	3	9 0.2×	30 1.0×	10 0.5×	11 0.5×	7 0.4×	6	58
Saori Amiya Japan	6	24 0.6×	37 1.2×	24 1.1×	4 0.2×	24 1.3×	7	85
Kenjiro Furuta Japan	6	32 0.8×	13 0.4×	71 3.2×	6 0.3×	11 0.6×	14	100
María del Valle Ortiz Spain	2	32 0.8×	43 1.4×	63 2.9×	27 1.3×	8 0.4×	5	105
Mario Caldararo United States	5	11 0.3×	34 1.1×	18 0.8×	8 0.4×	5 0.3×	12	73

Countries citing papers authored by L.S. Boers

Since Specialization

Citations

This map shows the geographic impact of L.S. Boers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.S. Boers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.S. Boers more than expected).

Fields of papers citing papers by L.S. Boers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.S. Boers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.S. Boers. The network helps show where L.S. Boers may publish in the future.

Co-authorship network of co-authors of L.S. Boers

This figure shows the co-authorship network connecting the top 25 collaborators of L.S. Boers. A scholar is included among the top collaborators of L.S. Boers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.S. Boers. L.S. Boers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Boers, L.S., et al.. (2025). Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome. European Respiratory Review. 34(175). 240153–240153.

Boerrigter, Bart, et al.. (2025). Alveolar cell composition in interstitial lung disease and the development of a pulmonary progressive fibrosing phenotype: a retrospective cohort study. Respiratory Research. 26(1). 164–164.

Brabander, Justin de, L.S. Boers, Robert F. J. Kullberg, et al.. (2023). Persistent alveolar inflammatory response in critically ill patients with COVID-19 is associated with mortality. Thorax. 78(9). 912–921. 15 indexed citations

Boers, L.S., Justin de Brabander, Robert F. J. Kullberg, et al.. (2023). The alveolar fibroproliferative response in moderate to severe COVID-19-related acute respiratory distress syndrome and 1-yr follow-up. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(1). L7–L18. 4 indexed citations

Philippot, Quentin, Arnaud Fekkar, Adrian Gervais, et al.. (2023). Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia. Journal of Clinical Immunology. 43(6). 1093–1103. 18 indexed citations

Kullberg, Robert F. J., Justin de Brabander, L.S. Boers, et al.. (2022). Lung Microbiota of Critically Ill Patients with COVID-19 Are Associated with Nonresolving Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 206(7). 846–856. 28 indexed citations

Valk, Christel M. A., L.S. Boers, Michela Botta, et al.. (2021). Practice of adjunctive treatments in critically ill COVID–19 patients—rational for the multicenter observational PRoAcT-COVID study in The Netherlands. Annals of Translational Medicine. 9(9). 813–813. 4 indexed citations

Boers, L.S., Michela Botta, Anna Geke Algera, et al.. (2020). PRactice of VENTilation in Patients with Novel Coronavirus Disease (PRoVENT-COVID): rationale and protocol for a national multicenter observational study in The Netherlands. Annals of Translational Medicine. 8(19). 1251–1251. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact